GE HealthCare Technologies Inc
For the period ended Dec 31, 2023. Filed Feb 6, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 6, 2024
GEHC$83.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated and Combined Statements of Cash Flows
| Consolidated and Combined Statements of Cash Flows | |||
|---|---|---|---|
| For the years ended December 31 | |||
| (In millions) | 2023 | 2022 | 2021 |
| Net income | $1,614 | $1,967 | $2,293 |
| Less: Income (loss) from discontinued operations, net of taxes | (4) | 18 | 18 |
| Net income from continuing operations | $1,618 | $1,949 | $2,275 |
| Adjustments to reconcile Net income from continuing operations to Cash from (used for) operating activities | |||
| Depreciation of property, plant, and equipment | 248 | 228 | 225 |
| Amortization of intangible assets | 362 | 405 | 400 |
| Gain on fair value remeasurement of contingent consideration | (17) | (65) | — |
| Net periodic postretirement benefit plan (income) expense | (332) | 9 | 25 |
| Postretirement plan contributions | (357) | (18) | (20) |
| Share-based compensation | 114 | 67 | 76 |
| Provision for income taxes | 743 | 563 | 600 |
| Cash paid during the year for income taxes | (474) | (851) | (615) |
| Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions: | |||
| Receivables | (185) | (231) | (1,336) |
| Due from related parties | 4 | 13 | 157 |
| Inventories | 111 | (402) | (435) |
| Contract and other deferred assets | 10 | (222) | 23 |
| Accounts payable | (13) | 481 | 263 |
| Due to related parties | (84) | (33) | (21) |
| Contract liabilities | 26 | 138 | (21) |
| All other operating activities | 327 | 103 | 11 |
| Cash from (used for) operating activities – continuing operations | 2,101 | 2,134 | 1,607 |
| Cash flows – investing activities | |||
| Additions to property, plant and equipment and internal-use software | (387) | (310) | (248) |
| Dispositions of property, plant, and equipment | 1 | 4 | 15 |
| Purchases of businesses, net of cash acquired | (147) | — | (1,481) |
| All other investing activities | (25) | (92) | (47) |
| Cash from (used for) investing activities – continuing operations | (558) | (398) | (1,761) |
| Cash flows – financing activities | |||
| Net increase (decrease) in borrowings (maturities of 90 days or less) | (12) | 9 | (7) |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | 2,006 | 8,198 | 5 |
| Repayments and other reductions (maturities longer than 90 days) | (855) | (3) | (10) |
| Dividends paid to stockholders | (41) | — | — |
| Redemption of noncontrolling interests | (211) | — | — |
| Net transfers (to) from GE | (1,317) | (8,934) | (238) |
| All other financing activities | (48) | (92) | (13) |
| Cash from (used for) financing activities – continuing operations | (478) | (822) | (263) |
| Cash from (used for) operating activities – discontinued operations | — | (21) | — |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | (10) | (3) | (34) |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 1,055 | 890 | (451) |
| Cash, cash equivalents, and restricted cash at beginning of year | 1,451 | 561 | 1,012 |
| Cash, cash equivalents, and restricted cash as of December 31 | $2,506 | $1,451 | $561 |
| Supplemental disclosure of cash flows information | |||
| Cash paid during the year for interest | $(570) | $— | $(21) |
| Non-cash investing activities | |||
| Acquired but unpaid property, plant, and equipment | $140 | $136 | $93 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.